COMMUNIQUÉS West-GlobeNewswire

Daré Bioscience, Inc. Enters into Agreement to Acquire Product to Address Vulvar and Vaginal Atrophy in Hormone Receptor-Positive Breast Cancer Patients
07/05/2018
Agreement intends to broaden Company’s product portfolio within women’s reproductive health with novel clinical candidate, positioning Company with first in class candidates in contraception, sexual health and vaginal [...]
Biotech Industry Veteran Dietmar Berger, M.D., Ph.D., Joins Atara Biotherapeutics as Global Head of Research and Development
07/05/2018
Expanded R&D leadership team focused on rigorous late-stage clinical development and leveraging full potential of Atara’s technology platform SOUTH SAN FRANCISCO, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Atara [...]
Optinose to Report First Quarter 2018 Financial Results and Corporate Updates on May 14, 2018
07/05/2018
Conference Call and Webcast Scheduled for Monday, May 14 at 8:00 a.m. Eastern Time YARDLEY, Pa., May 07, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, [...]
HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology
07/05/2018
TUCSON, Ariz. and HUNINGUE, France, May 07, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM ) (“HTG”), a provider of instruments, reagents and services for molecular profiling applications, and [...]
Rexahn Reports First Quarter 2018 Financial Results
07/05/2018
ROCKVILLE, Md., May 07, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, [...]
BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder
07/05/2018
The company will now have the most advanced stimulator on the market, with enhanced features that increase the ease of use for physicians and integrate a patient management system BrainsWay will be demonstrating the new [...]
Caladrius Biosciences to Participate at the 15th International Symposium on Cardiovascular Regeneration and Repair
07/05/2018
BASKING RIDGE, N.J. , May 07, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Wave Life Sciences Highlights Progress on Hepatic Collaboration with Pfizer
07/05/2018
With the designation of five targets, Pfizer nominates the maximum permitted under collaboration Collaboration moving toward candidate selection CAMBRIDGE, Mass., May 07, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd [...]
Krystal Biotech Reports First Quarter 2018 Financial Results and Provides Corporate Update
07/05/2018
IND for KB103 to treat dystrophic epidermolysis bullosa (DEB) cleared by FDA Patient enrollment in Phase 1/2 study of KB103 to begin in May 2018 at Stanford University Krystal Biotech’s KB103 receives Orphan Medicinal [...]
RedHill Biopharma Announces Last Patient Assessed for Primary Endpoint in RHB-104 Phase III Study for Crohn’s Disease
07/05/2018
Top-line results from the Phase III study with RHB-104 for Crohn’s disease are expected to be announced in approximately three months Worldwide sales of Crohn’s disease therapies are estimated to exceed $10 billion in [...]
PetMed Express, Inc. D/B/A 1-800-PetMeds Announces Record Earnings for its 4th Fiscal Quarter and its Quarterly Dividend of $0.25 per Share
07/05/2018
Fourth Quarter Net Income Increased 36% Fourth Quarter EPS $0.50 per share vs $0.37 per share DELRAY BEACH, Fla., May 07, 2018 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS ) today announced its financial [...]
Delcath Announces Initiation of Registrational Trial of Melphalan/HDS in Intrahepatic Cholangiocarcinoma
07/05/2018
Duke Medical Center Opens for Patient Enrollment NEW YORK, May 07, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic [...]
Transactions under Novozymes’ stock buyback program
07/05/2018
Please read the full announcement in the attached PDF Attachment 2018_26_Stock_Buybackprogram_EN
Auris Medical Receives Positive Scientific Advice from EMA on Development Plan and Regulatory Pathway for AM-111
07/05/2018
Design for single pivotal phase 3 trial validated by European Medicines Agency Regulatory pathway towards European market approval mapped out Strategy update scheduled together with earnings release for May 15, 2018 Zug [...]
Flexion Therapeutics Names David Arkowitz as Chief Financial Officer
07/05/2018
BURLINGTON, Mass., May 07, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that David Arkowitz has been named Chief Financial Officer (CFO). Mr. Arkowitz brings more than 25 years of [...]
Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2018 Financial Results on Thursday, May 10, 2018
07/05/2018
BOSTON, May 07, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced that it will [...]
Share buy-back week 18/2018
07/05/2018
Announcement 7 May 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up to [...]
Trading in Novo Nordisk shares by board members, executives and associated persons on 4 May 2018
07/05/2018
Bagsværd, Denmark, 7 May 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of [...]
Mike Weinstein to Join Medtronic as Senior Vice President of Strategy
07/05/2018
DUBLIN - May 7, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced the appointment of Mike Weinstein as Senior Vice President, Strategy. In this role, Weinstein will work with [...]

Pages